| Financial Year |
March 31 2023 |
| Monetary Funds |
3,513,066,013.40 |
| Held-for-trading Financial Assets |
950,619,305.30 |
| Notes Receivable |
270,303,743.34 |
| Accounts Receivable |
1,355,051,574.78 |
| Advances to Suppliers |
493,402,182.47 |
| Other Receivables |
117,686,994.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,284,397,155.05 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
390,594,865.03 |
| Total Current Assets |
11,715,483,931.09 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
97,846,407.70 |
| Investment Properties |
-- |
| Fixed Assetes |
2,170,060,182.71 |
| Under-construction Projects |
1,973,717,724.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
338,556,165.57 |
| R&D expenses |
-- |
| Goodwill |
362,598,304.21 |
| Long-Term Deferred and Prepaid Expenses |
141,720,860.78 |
| Deferred Income Tax Assets |
120,245,956.72 |
| Other Non-Current Assets |
387,368,488.75 |
| Sub-Total of Non-Current Assets |
5,954,969,425.81 |
| Total Assets |
17,670,453,356.90 |
| Short-Term Loans |
5,330,552,911.51 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,137,313,626.54 |
| Accounts Payable |
2,128,582,329.09 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
48,397,221.70 |
| Taxes Payable |
50,691,739.29 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
49,861,738.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
672,678,115.89 |
| Other Current Liabilities |
18,047,023.60 |
| Sub-Total of Current Liabilities |
9,548,241,448.42 |
| Long-term Loans |
1,999,820,080.14 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
114,827,180.49 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,299,589.53 |
| Other Non-Current Liabilities |
345,000,000.00 |
| Sub-Total of Non-Current Liabilities |
2,767,818,114.76 |
| Total Liabilities |
12,316,059,563.18 |
| Paid-In Capital(Or Share Stock) |
565,078,903.00 |
| Capital Surplus |
2,588,181,656.98 |
| Surplus Reserve |
79,751,116.00 |
| LESS:Treasury Stock |
50,271,636.84 |
| Undistributed Profits |
1,280,903,662.15 |
| Minority Stockholder's Interest |
889,761,718.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,464,632,075.63 |
| Owner's Equity（Stockholder's Equity） |
5,354,393,793.72 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,670,453,356.90 |
